Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.570
-0.020 (-0.56%)
At close: Sep 1, 2026, 4:00 PM EDT
3.540
-0.030 (-0.84%)
After-hours: Sep 1, 2026, 7:47 PM EDT
Prime Medicine Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 47.45 | 63.03 | 182.48 | 41.57 | 187.62 | 185.42 |
Short-Term Investments | 47.62 | 114.65 | 7.97 | 80.09 | 106.3 | 84.2 |
Cash & Short-Term Investments | 95.07 | 177.68 | 190.44 | 121.67 | 293.92 | 269.62 |
Cash Growth | -6.56% | -6.70% | 56.53% | -58.61% | 9.01% | 405.59% |
Prepaid Expenses | 1.36 | 2.94 | 6.78 | 19.06 | 2.45 | 0.96 |
Other Current Assets | 0.38 | 0.67 | 14.67 | 2.25 | 0.25 | - |
Total Current Assets | 96.8 | 181.29 | 211.89 | 142.98 | 296.62 | 270.58 |
Property, Plant & Equipment | 137.55 | 146.75 | 71.56 | 36.6 | 48.55 | 15.68 |
Other Long-Term Assets | 14.69 | 14.69 | 14.06 | 14.28 | 15.14 | 15.6 |
Total Assets | 249.04 | 342.73 | 297.51 | 193.85 | 360.31 | 301.86 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 5.81 | 8.89 | 11.35 | 19.54 | 4.33 | 1.44 |
Accrued Expenses | 8.06 | 10.9 | 11.82 | 10.23 | 9.02 | 36.19 |
Current Portion of Leases | 8.97 | 8.14 | 3.61 | 9.28 | 11.69 | 7.34 |
Current Unearned Revenue | 7.93 | 7.82 | 7.09 | - | - | - |
Other Current Liabilities | 0.92 | 1.7 | 4.08 | 17.38 | 1.67 | 13.02 |
Total Current Liabilities | 31.69 | 37.45 | 37.96 | 56.42 | 26.71 | 57.98 |
Long-Term Leases | 103.51 | 108.29 | 37.18 | 4.36 | 17.05 | 3.07 |
Long-Term Unearned Revenue | 56.03 | 58.13 | 63.22 | - | - | - |
Long-Term Deferred Tax Liabilities | - | - | - | - | 0.28 | 1.24 |
Other Long-Term Liabilities | 18 | 18 | 6 | - | - | - |
Total Liabilities | 209.23 | 221.87 | 144.36 | 60.78 | 44.04 | 62.3 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | 0 | 0 | 0 | - |
Additional Paid-In Capital | 1,019 | 1,009 | 840.36 | 624.41 | 609.85 | 15.16 |
Retained Earnings | -979.59 | -888.35 | -687.21 | -491.33 | -293.2 | -171.38 |
Comprehensive Income & Other | -0.01 | 0.08 | 0 | -0.02 | -0.38 | -0.03 |
Total Common Equity | 39.81 | 120.87 | 153.15 | 133.07 | 316.27 | -156.24 |
Shareholders' Equity | 39.81 | 120.87 | 153.15 | 133.07 | 316.27 | 239.56 |
Total Liabilities & Equity | 249.04 | 342.73 | 297.51 | 193.85 | 360.31 | 301.86 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 112.48 | 116.43 | 40.79 | 13.63 | 28.75 | 10.41 |
Net Cash (Debt) | -17.41 | 61.25 | 149.65 | 108.03 | 265.18 | 259.21 |
Net Cash Growth | - | -59.07% | 38.52% | -59.26% | 2.30% | 623.80% |
Net Cash Per Share | -0.10 | 0.41 | 1.26 | 1.19 | 7.82 | 19.98 |
Filing Date Shares Outstanding | 177.9 | 177.08 | 127.66 | 115.2 | 88.4 | 17.06 |
Total Common Shares Outstanding | 177.27 | 177.04 | 127.66 | 92.64 | 88.36 | 17.06 |
Working Capital | 65.11 | 143.85 | 173.93 | 86.55 | 269.9 | 212.6 |
Book Value Per Share | 0.22 | 0.68 | 1.20 | 1.44 | 3.58 | -9.16 |
Tangible Book Value | 39.81 | 120.87 | 153.15 | 133.07 | 316.27 | -156.24 |
Tangible Book Value Per Share | 0.22 | 0.68 | 1.20 | 1.44 | 3.58 | -9.16 |
Machinery | 33.19 | 32.73 | 29.29 | 24.16 | 19.67 | 5.42 |
Construction In Progress | 0.05 | 0.37 | 3.58 | 5.4 | 1.61 | - |
Leasehold Improvements | 7.91 | 7.91 | 5.14 | 0.58 | 0.56 | 0.13 |